HHTG(600095)
Search documents
湘财股份(600095) - 2018 Q4 - 年度财报
2019-03-21 16:00
Financial Performance - The company's operating revenue for 2018 was CNY 299,404,615.70, representing a 34.52% increase compared to CNY 222,566,306.88 in 2017[15] - The net profit attributable to shareholders for 2018 was CNY 15,136,624.53, a decrease of 27.72% from CNY 20,941,340.59 in 2017[15] - The net cash flow from operating activities was CNY 30,833,741.32, down 48.23% from CNY 59,561,726.30 in 2017[15] - The basic earnings per share for 2018 were CNY 0.0419, a decrease of 27.72% compared to CNY 0.0580 in 2017[18] - The weighted average return on net assets for 2018 was 2.0454%, a decrease of 0.817 percentage points from 2.8624% in 2017[18] - The net profit after deducting non-recurring gains and losses for 2018 was CNY 14,925,956.26, an increase of 24.03% from CNY 12,033,824.55 in 2017[15] - The company achieved a year-on-year revenue increase of 34.52% for the reporting period, while the net profit attributable to shareholders decreased by 27.72%[27] - The company reported a net profit of ¥35,646,300 from Haoyun Holdings, impacting the overall net profit by ¥21,387,800[42] Asset and Liability Management - The total assets at the end of 2018 were CNY 1,094,515,095.41, an 8.49% decrease from CNY 1,001,559,747.40 at the end of 2017[17] - The company's net assets attributable to shareholders at the end of 2018 were CNY 735,727,821.40, a slight decrease of 1.17% from CNY 744,361,701.76 at the end of 2017[17] - Total liabilities decreased from ¥330,769,244.69 to ¥226,442,018.71, a decline of approximately 31.6%[150] - Total equity attributable to shareholders increased from ¥735,727,821.40 to ¥744,361,701.76, an increase of approximately 1.9%[151] Revenue Breakdown by Segment - The residential real estate segment achieved revenue of CNY 113.44 million in 2018, a decrease of CNY 3.58 million year-on-year, while net profit increased by CNY 4.31 million to CNY 35.44 million[30] - The industrial real estate segment reported revenue of CNY 57.12 million, an increase of CNY 29.63 million year-on-year, with net profit rising by CNY 4.74 million to CNY 4.81 million[30] - The waterproof membrane business generated revenue of CNY 22.64 million, up CNY 0.28 million year-on-year, with net profit increasing by CNY 0.68 million to CNY 0.94 million, and sales volume of waterproof membranes reached 2.22 million square meters, a 47.7% increase[30] - The soybean deep processing segment recorded revenue of CNY 36.03 million, an increase of CNY 16.09 million year-on-year, but still reported a net loss of CNY 12.11 million, although the loss was reduced by CNY 1.46 million[30] - The pharmaceutical segment achieved revenue of CNY 3.26 million, an increase of CNY 0.32 million year-on-year, but incurred a net loss of CNY 18.23 million, a reduction in loss by CNY 1.95 million[30] Cash Flow Analysis - The net cash flow from operating activities was CNY 30,833,741.32, a decrease of 48.23% compared to the previous year[31] - Cash received from operating activities increased significantly, with a rise of 551.01% compared to the previous year, primarily due to increased receivables[41] - The net cash flow from operating activities was ¥42,671,530.35, a significant improvement compared to the previous period's net cash flow of -¥10,480,259.07, indicating a recovery in operational efficiency[162] Investment and Financing Activities - The company has a total financing amount of ¥16,276.47 million at the end of the period, with an average financing cost of 5.94%[54] - The company has pledged its equity in Wenzhou Bank for a loan of ¥200 million, with a guarantee period until March 2019[45] - The company has entrusted RMB 80 million in self-owned funds for bank wealth management, with no overdue amounts[94] - The company signed a contract for a total entrusted loan of RMB 100 million, with RMB 20 million disbursed by the end of 2018[98] Corporate Governance and Management - The company has a diverse management team with extensive experience in finance and investment management[121] - The independent directors have backgrounds in law and finance, enhancing corporate governance[121] - The board of directors consists of five members, including two independent directors, and has held 11 meetings during the year, with all members actively participating[132] - The company has not granted any equity incentives to its directors and senior management during the reporting period[122] Legal and Compliance Matters - The company is involved in significant litigation, with a total amount of 590.23 thousand RMB claimed in a lawsuit against Qingdao Lingang Real Estate Co., Ltd. for construction payments and delayed payments[78] - The company has no significant litigation or arbitration matters that have not been disclosed in temporary announcements[77] - The company has complied with all legal procedures regarding its financial activities[95][97] Future Outlook and Strategic Plans - The company plans to expand its market presence, leveraging its technological advancements and established product lines in the waterproof materials sector[26] - The company aims to clear the "Songhua River·Shang" residential project and enhance sales of commercial properties and parking spaces in 2019[64] - The company plans to expand its pharmaceutical market by developing existing products and exploring new market potentials[64] - The waterproof membrane business will focus on increasing sales capacity and enhancing product competitiveness through R&D and innovation[64]
湘财股份(600095) - 2018 Q3 - 季度财报
2018-10-30 16:00
2018 年第三季度报告 1 / 21 | 目录 | | --- | | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 6 | | 四、 | 附录 | 7 | 2018 年第三季度报告 公司代码:600095 公司简称:哈高科 哈尔滨高科技(集团)股份有限公司 2018 年第三季度报告 一、 重要提示 1.1 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整, 不存在虚假记载、误导性陈述或者重大遗漏,并承担个别和连带的法律责任。 1.2 公司全体董事出席董事会审议季度报告。 1.3 公司负责人史建明、主管会计工作负责人詹超及会计机构负责人(会计主管人员)李萌保证 季度报告中财务报表的真实、准确、完整。 1.4 本公司第三季度报告未经审计。 二、 公司基本情况 2.1 主要财务数据 3 / 21 单位:元 币种:人民币 本报告期末 上年度末 本报告期末比上年度 末增减(%) 总资产 1,044,159,974.55 1,094,515,095.41 -4.60 归属于上市公司股东 的净资产 ...
湘财股份(600095) - 2018 Q2 - 季度财报
2018-08-27 16:00
Financial Performance - The company's operating revenue for the first half of 2018 was ¥69,874,513.07, representing an increase of 8.27% compared to ¥64,539,981.52 in the same period last year[15]. - The net profit attributable to shareholders of the listed company was -¥12,803,007.97, compared to -¥11,784,459.62 in the previous year, indicating a continued loss[15]. - The net cash flow from operating activities was -¥655,182.24, an improvement from -¥1,343,628.69 in the same period last year[15]. - The basic earnings per share for the first half of 2018 was -¥0.0354, compared to -¥0.0326 in the same period last year[16]. - The company reported a net profit of -7.56 million RMB for the first half of 2018, impacting the company's net profit by -2.35 million RMB[43]. - The company reported a significant increase in prepayments from 2,114,942.11 RMB to 11,041,410.63 RMB, an increase of over 420%[69]. - The company reported a significant increase in other payables from CNY 50,435,804.71 to CNY 31,585,203.78, a decrease of approximately 37.4%[70]. - The company reported a total comprehensive loss for the current period of RMB 15,139,945.19, compared to a loss of RMB 14,942,276.61 in the previous period[76]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,025,750,654.92, down 6.28% from ¥1,094,515,095.41 at the end of the previous year[15]. - The net assets attributable to shareholders of the listed company decreased by 2.62% to ¥716,422,069.26 from ¥735,727,821.40 at the end of the previous year[15]. - Cash and cash equivalents decreased by 32.63% to ¥160,823,752.18, primarily due to payments for investments and construction costs[32]. - Total liabilities decreased from CNY 330,769,244.69 to CNY 283,647,493.56, a reduction of approximately 14.2%[70]. - Current liabilities increased from CNY 147,170,459.52 to CNY 189,846,056.49, an increase of about 28.9%[70]. - Non-current liabilities decreased significantly from CNY 183,598,785.17 to CNY 93,801,437.07, a decrease of approximately 48.9%[70]. - The total value of restricted assets is ¥196,553,669.03, primarily due to loan guarantees and pledges[34]. Investments and Subsidiaries - The company operates in various sectors including real estate, property management, waterproof materials, pharmaceuticals, and soybean processing, with a focus on "industrial operation + equity investment" as its business model[20]. - The company has investments in Wenzhou Bank, Puni Company, and Haoyun Holdings, which are part of the financial services sector[20]. - The company invested ¥30 million to establish a wholly-owned subsidiary, Zhejiang Hagaoke Investment Management Co., Ltd.[36]. - The company holds a 52.86% stake in Qingdao Lingang Real Estate Co., Ltd., which reported total assets of ¥14,439.28 million[38]. - The company’s investment in Puni Company resulted in a significant revenue drop of 67.13% to 8.31 million yuan, leading to increased losses of 755.67 thousand yuan[26]. Cash Flow - Operating cash inflow for the first half of 2018 was CNY 112,554,697.97, an increase from CNY 107,581,408.38 in the previous period[80]. - Net cash flow from operating activities was negative CNY 655,182.24, an improvement from negative CNY 1,343,628.69 year-on-year[80]. - Cash and cash equivalents at the end of the period stood at CNY 160,823,752.18, down from CNY 239,779,694.09 in the previous year[80]. - Total cash outflow from financing activities was CNY 25,222,564.67, compared to CNY 10,194,510.56 in the previous period, indicating increased outflows[80]. - The company reported a net cash outflow of CNY 15,097,438.39 from cash and cash equivalents for the first half of 2018, an improvement from CNY 57,221,555.60 in the previous period[82]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period is 48,313[58]. - There were no changes in the total number of shares or the share capital structure during the reporting period[56]. - Zhejiang Xinh Lake Group Co., Ltd. holds 58,094,308 shares, accounting for 16.08% of total shares[60]. - Yunnan International Trust Co., Ltd. reduced its holdings by 1,945,899 shares, ending with 9,200,000 shares, representing 2.55%[60]. Compliance and Governance - The company has not proposed any profit distribution or capital reserve transfer plan for the half-year period[46]. - There are no significant litigation or arbitration matters reported during the reporting period[47]. - The company has committed to not engaging in residential real estate development and sales within China after completing existing projects[46]. - The company has not disclosed any significant changes in its equity incentive plans or employee stock ownership plans[48]. - The company has not faced any major risks or warnings regarding potential losses compared to the previous year[44]. Environmental and Social Responsibility - The company has two subsidiaries involved in pollution discharge, both complying with national first-level discharge standards[54]. - The wastewater discharge from one subsidiary is 10,000 tons annually, with no exceeding of discharge standards reported[54]. - The company has established emergency response plans and environmental monitoring schemes for its subsidiaries[54]. Accounting Policies - The financial statements are prepared based on the assumption of going concern and comply with the relevant accounting standards[96][97]. - The company’s accounting policies comply with the requirements of the accounting standards and accurately reflect its financial status[98]. - The company has not made any changes to its significant accounting policies or estimates during the reporting period[181]. - The company recognizes revenue from sales when the significant risks and rewards of ownership have transferred to the buyer[169].
湘财股份(600095) - 2018 Q1 - 季度财报
2018-04-27 16:00
2018 年第一季度报告 公司代码:600095 公司简称:哈高科 哈尔滨高科技(集团)股份有限公司 2018 年第一季度报告 1 / 18 | 一、 | 重要提示 | 3 | | --- | --- | --- | | 二、 | 公司基本情况 | 3 | | 三、 | 重要事项 | 5 | | 四、 | 附录 | 7 | 2018 年第一季度报告 一、 重要提示 二、 公司基本情况 2.1 主要财务数据 单位:元 币种:人民币 | | 本报告期末 | 上年度末 | 本报告期末比 上年度末增减 | | --- | --- | --- | --- | | | | | (%) | | 总资产 | 1,051,856,316.48 | 1,094,515,095.41 | -3.90 | | 归属于上市公司股东的 | 730,326,641.04 | 735,727,821.40 | -0.73 | | 净资产 | | | | | | 年初至报告期末 | 上年初至上年报告 | 比上年同期增 | | | | 期末 | 减(%) | | 经营活动产生的现金流 | 4,228,366.71 | -9,620,613.74 ...
湘财股份(600095) - 2017 Q4 - 年度财报
2018-03-22 16:00
Financial Performance - The company's total revenue for 2017 was CNY 222,566,306.88, a decrease of 12.46% compared to CNY 254,243,478.05 in 2016[19]. - The net profit attributable to shareholders for 2017 was CNY 20,941,340.59, an increase of 36.18% from CNY 15,377,263.71 in 2016[19]. - The net profit after deducting non-recurring gains and losses was CNY 12,033,824.55, a significant increase of 809.30% compared to CNY 1,323,413.93 in 2016[19]. - The net cash flow from operating activities for 2017 was CNY 59,561,726.30, down 52.32% from CNY 124,911,091.01 in 2016[19]. - The company achieved operating revenue of 222.57 million yuan, a year-on-year decrease of 12.46%[34]. - The net profit attributable to shareholders increased by 36.18% to 20.94 million yuan[34]. - Basic earnings per share rose to 0.058 yuan, while diluted earnings per share also stood at 0.058 yuan, reflecting a 36.18% increase[34]. - The weighted average return on equity increased by 0.73 percentage points to 2.86%[34]. - The company reported a significant decrease in sales volume for key products, including a 30.53% drop in sales revenue for isolated protein products[50]. Assets and Liabilities - As of the end of 2017, the total assets amounted to CNY 1,094,515,095.41, a decrease of 2.22% from CNY 1,119,352,647.86 at the end of 2016[19]. - Total assets decreased from CNY 1,119,352,647.86 to CNY 1,094,515,095.41, a decline of approximately 2.3%[168]. - Total liabilities decreased from CNY 362,714,099.35 to CNY 330,769,244.69, a decline of about 8.8%[169]. - Current liabilities decreased from CNY 163,701,398.17 to CNY 147,170,459.52, a reduction of approximately 10.1%[169]. - Long-term borrowings decreased from CNY 191,915,000.00 to CNY 178,915,000.00, a decrease of about 6.8%[169]. - Owner's equity increased from CNY 756,638,548.51 to CNY 763,745,850.72, an increase of approximately 0.15%[169]. Dividends and Profit Distribution - The company plans to distribute a cash dividend of CNY 0.18 per 10 shares, totaling CNY 6,502,744.17[5]. - The proposed cash dividend for 2017 is CNY 0.18 per 10 shares, totaling CNY 6,502,744.17, which represents 31.05% of the net profit[92]. - In 2017, the company achieved a net profit attributable to shareholders of CNY 20,941,340.59, with undistributed profits amounting to CNY 70,806,285.06 as of December 31, 2017[92]. Business Segments - The real estate segment generated the highest revenue, followed by property management and waterproofing materials production[34]. - The residential real estate project "Songhua River·Shang" contributed significantly, with sales of 42 residential units and 1 commercial unit in 2017[34]. - The industrial real estate segment reported revenue of CNY 2,749.55 million, a significant increase of 846.17% year-on-year, although net profit decreased by 93.95% to CNY 6.71 million[41]. - The property management subsidiary generated revenue of CNY 2,828.46 million with a net profit of CNY 639.31 million, managing a total area of 21.9 million square meters across residential and industrial properties[35]. - The waterproof membrane business reported revenue of CNY 2,235.98 million, with a sales volume of 150.30 million square meters, reflecting a 2.7% year-on-year decline[36]. - The soybean processing subsidiary recorded revenue of CNY 1,945.14 million but incurred a loss of CNY 1,357.02 million due to market competition and outdated equipment[37]. - The pharmaceutical subsidiary, after restructuring, achieved revenue of CNY 294.43 million but faced a loss of CNY 2,017.92 million due to a significant drop in product sales[37]. Investments and Acquisitions - The company acquired a 45% stake in Haoyun Holdings for 150 million yuan in September 2017[31]. - The company participated in a rights issue of Wenzhou Bank, acquiring 9,124,943 shares for approximately 36.13 million yuan[31]. - The company sold 168,000 shares of AVIC Capital for a profit of CNY 960.90 million, enhancing its financial position[38]. - The company received CNY 456.25 million in cash dividends from its holdings in Wenzhou Bank, increasing its total shareholding to 54,749,658 shares, representing 1.85% of the bank's total equity[38]. Research and Development - Research and development expenses increased by 17.77% to 2.87 million yuan, indicating a focus on innovation despite overall financial challenges[46]. - The company is focusing on technological innovation and new product development in the waterproof membrane sector to improve product competitiveness[36]. Environmental Compliance - The company has established emergency response plans and environmental monitoring schemes for both subsidiaries to mitigate environmental impact[117][118]. - The company maintains compliance with environmental regulations, with all necessary environmental assessments and administrative permits in place for its subsidiaries[118]. Corporate Governance - The company completed the election of a new board of directors and supervisory board on January 15, 2018, appointing new management team members[133]. - The company has established a comprehensive internal control system in compliance with relevant laws and regulations, ensuring operational independence from its controlling shareholder[143]. - The total remuneration for all directors, supervisors, and senior management during the reporting period amounted to 1.8516 million yuan[136]. Future Outlook - The company plans to focus on market expansion and new product development in the upcoming fiscal year[173]. - The company aims to complete the certification of its biochemical drug raw material extraction workshop and solid preparation workshop as soon as possible in 2018[88]. - The company will explore new property management models under the "Internet+" initiative to improve service quality and customer satisfaction[88].
湘财股份(600095) - 2017 Q3 - 季度财报
2017-10-30 16:00
Financial Performance - Operating income for the first nine months was CNY 123,623,883.31, down 19.56% year-on-year[6] - Net profit attributable to shareholders of the listed company was CNY 6,157,141.44, a significant recovery from a loss of CNY 11,582,395.55 in the same period last year[6] - The company reported a net loss of CNY 43.33 million, improving from a loss of CNY 47.72 million in the previous period[22] - Net profit for the quarter was $16.95 million, compared to a net loss of $3.08 million in the same quarter last year[25] - The total profit margin improved significantly, with a profit margin of 36.3% compared to a negative margin in the previous year[24] - The company reported a significant increase in investment income, reaching CNY 18,697,283.25, compared to CNY 2,487,804.17 in the previous year[27] - The total comprehensive income for the first nine months was CNY 9,810,520.79, a recovery from a loss of CNY 7,610,831.77 in the previous year[27] Cash Flow and Investments - The net cash flow from operating activities increased by 447.19% to CNY 39,684,202.19 compared to the same period last year[6] - Cash and cash equivalents decreased by 35.67% to CNY 182,751,008.46 due to investments in Haoyun Holdings Group[10] - Cash received from investment income was ¥8,781,255.85, a dramatic increase of 4064.89% compared to the previous period, attributed to cash dividends declared in 2015 and 2016 from Wenzhou Bank.[12] - The company’s cash flow from the recovery of investments was ¥111,969,334.83, reflecting a substantial increase of 157242.55% due to cumulative redemptions of bank wealth management products.[12] - Investment activities resulted in a net cash outflow of CNY 121,371,194.41, which is a deterioration from a net outflow of CNY 60,103,105.60 in the previous year[29] - Cash inflow from financing activities was 120,000,000.00 RMB, while cash outflow totaled 22,764,637.02 RMB, leading to a net cash flow of -22,764,637.02 RMB[31] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,119,182,882.85, a decrease of 0.02% compared to the end of the previous year[6] - Total liabilities increased to CNY 372.62 billion from CNY 362.71 billion year-over-year, reflecting a growth of approximately 2.5%[19] - Current assets decreased significantly to CNY 202.57 million from CNY 355.65 million, a decline of about 43%[21] - Long-term equity investments rose to CNY 719.05 million, up from CNY 615.52 million, indicating an increase of approximately 16.8%[21] - Owner's equity totaled CNY 601.73 million, slightly down from CNY 604.60 million, a decrease of around 0.45%[22] Shareholder Information - The total number of shareholders at the end of the reporting period was 44,397[8] - Basic and diluted earnings per share were CNY 0.0170, recovering from a loss of CNY 0.0321 per share in the previous year[6] - The basic earnings per share for the first nine months was CNY 0.0272, compared to a loss per share of CNY 0.0211 in the same period last year[27] Future Outlook and Plans - The company plans to complete the technical upgrade of its biochemical raw material extraction workshop by November 2017, with expectations of resuming production after obtaining GMP certification.[12] - The company plans to focus on expanding its long-term equity investments and enhancing its cash flow management strategies moving forward[23] - The company plans to focus on market expansion and new product development to drive future growth[24] - The company’s management indicated a focus on improving operational efficiency and exploring new market opportunities in future quarters[27]
湘财股份(600095) - 2017 Q2 - 季度财报
2017-08-30 16:00
Financial Performance - The company's operating revenue for the first half of 2017 was ¥64,539,981.52, a decrease of 41.37% compared to ¥110,079,164.95 in the same period last year[15]. - The net profit attributable to shareholders for the first half of 2017 was a loss of ¥11,784,459.62, compared to a loss of ¥8,870,542.03 in the previous year[15]. - The net cash flow from operating activities for the first half of 2017 was -¥1,343,628.69, an improvement from -¥18,441,194.39 in the same period last year[15]. - The total assets at the end of the reporting period were ¥1,102,933,226.70, down 1.47% from ¥1,119,352,647.86 at the end of the previous year[15]. - The net assets attributable to shareholders decreased by 2.45% to ¥709,670,392.29 from ¥727,466,005.39 at the end of the previous year[15]. - The basic earnings per share for the first half of 2017 was -¥0.0326, compared to -¥0.0246 in the same period last year[16]. - The company anticipates a full-year loss for 2017 due to ongoing operational challenges[2]. - The company achieved operating revenue of 64.54 million yuan in the first half of 2017, a decrease of 41.37% compared to the same period last year[31]. - The net profit attributable to shareholders was -11.78 million yuan, an increase in loss of 291.39 thousand yuan year-on-year[27]. - The revenue from the real estate sector decreased by 3.13 million yuan, while the pharmaceutical sector saw a decline of 14.86 million yuan year-on-year[31]. - The company’s investment income increased by 41.90%, reaching 4.25 million yuan, attributed to reduced losses from the equity method accounting of Punie Company[31]. - The company’s R&D expenditure increased significantly by 896.94%, totaling 168.81 thousand yuan, indicating a focus on innovation[31]. - The company’s sales expenses decreased by 59.01%, amounting to 4.35 million yuan, reflecting cost-cutting measures in response to declining revenues[31]. - The company anticipates a full-year loss for 2017, reflecting challenges in its operational performance[37]. Investments and Subsidiaries - The company participated in a share placement of Wenzhou Bank, acquiring 9,124,943 shares for a total amount of 36.13 million yuan, increasing its stake to 1.85%[22]. - The company participated in the Wenzhou Bank's rights issue, acquiring 9,124,943 shares for a total amount of 36,134,774.28 yuan, resulting in a 1.85% ownership stake post-expansion[36]. - The company’s subsidiary, Harbin High-tech Group Real Estate Development Co., Ltd., reported total assets of 416.76 million yuan and a net profit of 7.05 million yuan for the first half of 2017[40]. - Another subsidiary, Harbin High-tech Dried Bean Products Co., Ltd., reported total assets of 225.70 million yuan but incurred a net loss of 7.16 million yuan in the same period[41]. - The company’s subsidiary, Harbin High-tech White Swan Pharmaceutical Group, reported total assets of 114.20 million yuan and a net loss of 7.97 million yuan for the first half of 2017[42]. - The company’s subsidiary, Harbin High-tech Property Management Co., Ltd., achieved a net profit of 1.03 million yuan, with total assets of 25.48 million yuan[45]. - The company’s investment in Zhonghang Capital had an initial cost of 600,838.53 yuan, with a fair value change amounting to 789,600.00 yuan, contributing to other comprehensive income[39]. - The company’s investment in structural deposits totaled 40 million yuan, with fair value changes of 110,500.00 yuan and 114,750.00 yuan respectively[39]. - The company’s investment in Qingdao Lingang Real Estate Co., Ltd. resulted in a net loss impact of 256.18 thousand yuan, with total assets of 171.85 million yuan[43]. Shareholder Information - As of the end of the reporting period, the total number of ordinary shareholders is 45,482[68]. - The largest shareholder, Zhejiang Xinhuh Group Co., Ltd., holds 58,094,308 shares, accounting for 16.08% of the total shares[69]. - The second-largest shareholder, Guojin Securities - Industrial and Commercial Bank of China, holds 9,000,000 shares, representing 2.49%[70]. - The company has not made any changes to its share capital structure during the reporting period[66]. - There are no changes in the controlling shareholder or actual controller during the reporting period[71]. - Zhejiang Xinhu Group Co., Ltd. reduced its shareholding in the company by 15 million shares, representing a decrease of approximately 4.42% of the total share capital[101]. Financial Position and Cash Flow - Total current assets decreased from ¥756,191,832.75 to ¥710,152,730.59, a decline of approximately 6.09%[77]. - Cash and cash equivalents decreased from ¥284,086,226.58 to ¥239,779,694.09, a decrease of about 15.6%[77]. - Accounts receivable increased from ¥35,322,136.19 to ¥37,474,190.90, an increase of approximately 6.09%[77]. - Inventory decreased from ¥337,579,560.18 to ¥325,698,673.64, a decline of about 3.5%[77]. - Total non-current assets increased from ¥363,160,815.11 to ¥392,780,496.11, an increase of approximately 8.2%[77]. - Total liabilities increased from ¥362,714,099.35 to ¥366,655,908.28, an increase of about 1.1%[78]. - Total equity attributable to shareholders decreased from ¥727,466,005.39 to ¥709,670,392.29, a decline of approximately 2.4%[78]. - The company reported a decrease in undistributed profits from ¥55,283,897.95 to ¥38,080,484.85, a decrease of about 30.9%[78]. - The company’s total assets decreased from ¥1,119,352,647.86 to ¥1,102,933,226.70, a decline of approximately 1.5%[78]. - The company maintained long-term borrowings at ¥191,915,000.00, unchanged from the previous period[78]. - The company reported a total of ¥28.27 million in accounts receivable classified by credit risk characteristics, with a bad debt provision of approximately ¥19.60 million, representing a provision rate of 69.32%[200]. - The company’s cash balance decreased from ¥101.45 thousand to ¥97.34 thousand, reflecting a decline of about 3.1%[195]. - The company’s bank deposits decreased from approximately ¥283.70 million to ¥239.42 million, a decline of about 15.6%[195]. Accounting Policies and Compliance - The financial statements are prepared based on the assumption of going concern and comply with the relevant accounting standards[105][106]. - The accounting period for the company is from January 1 to December 31 each year[109]. - The company uses RMB as its functional currency for accounting purposes[111]. - The company ensures that all financial reporting complies with applicable accounting standards and reflects the economic reality of its operations[168]. - The company implemented changes in accounting policies according to the Ministry of Finance's notification, which had no significant impact on the financial statements[190].
湘财股份(600095) - 2017 Q1 - 季度财报
2017-04-28 16:00
Financial Performance - Operating revenue fell by 32.52% to CNY 35,860,207.48 year-on-year[6] - Net profit attributable to shareholders was a loss of CNY 8,333,538.65, compared to a loss of CNY 2,428,023.49 in the same period last year[6] - Basic and diluted earnings per share were both -0.0217 CNY, compared to -0.0067 CNY in the same period last year[6] - Total operating revenue for Q1 2017 was ¥35,860,207.48, a decrease of 32.5% compared to ¥53,140,905.09 in the same period last year[20] - Net profit for Q1 2017 was -¥9,284,402.81, compared to -¥3,582,621.82 in Q1 2016, representing a 158.5% increase in losses[20] - The company recorded a total comprehensive loss of -¥9,246,602.81 for Q1 2017, compared to -¥6,220,221.82 in Q1 2016, indicating a 48.7% increase in comprehensive losses[20] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 9,620,613.74, contrasting with a net inflow of CNY 2,708,631.20 in the previous year[6] - Cash received from operating activities decreased to ¥32,552,208.49, down 48.0% from ¥62,690,373.70 in the previous year[23] - The net cash flow from operating activities for Q1 2017 was -37,359,109.59 RMB, compared to -7,867,352.15 RMB in the previous period, indicating a significant decline in operational performance[26] - The total cash outflow for operating activities was 55,542,699.42 RMB, compared to 134,443,758.61 RMB in the previous period, showing a reduction in operational cash outflows[26] - The company experienced a net decrease in cash and cash equivalents of -77,201,328.27 RMB during the quarter, compared to a smaller decrease of -6,817,127.10 RMB in the previous period[26] Assets and Liabilities - Total assets decreased by 2.10% to CNY 1,095,921,800.73 compared to the end of the previous year[6] - Current assets totaled CNY 701,110,204.30, a decrease from CNY 756,191,832.75 at the beginning of the year[15] - Total liabilities decreased from CNY 464,621,171.29 to CNY 450,985,756.82, a reduction of approximately 2.8%[18] - Total equity decreased from CNY 604,597,212.04 to CNY 599,539,033.44, a reduction of approximately 0.9%[18] - Cash and cash equivalents decreased from CNY 215,694,573.67 to CNY 138,493,245.40, a decline of about 35.9%[17] Expenses - Operating costs decreased by 30.39% to CNY 21,147,327.91 from CNY 30,380,756.52 year-on-year[11] - Sales expenses fell by 36.76% to CNY 2,042,114.47 compared to CNY 3,229,343.92 in the previous year[11] - Financial expenses increased by 92.59% to CNY 2,683,065.88 due to a higher balance of bank loans compared to the same period last year[11] - The company incurred financial expenses of ¥2,683,065.88 in Q1 2017, which is a 92.7% increase from ¥1,393,176.34 in the same period last year[20] Shareholder Information - The number of shareholders totaled 34,306 at the end of the reporting period[8] - The largest shareholder, Zhejiang Xinhuhua Group Co., Ltd., held 16.08% of the shares, totaling 58,094,308 shares[8] Government Support and Other Income - The company received government subsidies amounting to CNY 58,679.07, which are closely related to its normal business operations[9] - The company reported a fair value change gain of CNY 458,630.14 from trading financial assets and liabilities[9] - Other comprehensive income after tax for Q1 2017 was ¥37,800.00, compared to -¥2,637,600.00 in the same period last year, showing a significant recovery[21] Investment and Capital Expenditures - The company reported a significant decrease in the construction in progress, primarily due to renovations at Harbin High-tech White Swan Pharmaceutical Group Co., Ltd.[10] - The total cash outflow from investing activities was 36,134,774.28 RMB, significantly higher than the previous period's outflow of 12,200,000.00 RMB, indicating increased investment expenditures[26]